That would be much worse for the common shareholders because once they have control of the company they will also control all assets and upon liguidation the commons will get nothing for their shares.. Holmes being the CEO of Pharmachem now owns 15m shares...Why he added nearly 8M shares to his already owned 7M shares gained from his share of Series J dividends is a mystery.. Below are some possibilities of why: 1. He forsees NXXI soon becoming quite profitable.. 2. He and the Company are planning a merger of some type.. 3. He is assisting the Consortium of Series J Shareholder's effort to gain 51% or more of the common shares to do a takeover of management.. One thing we do know is that a CEO from a "competive" company rarely purchases a large block of shares in their competition without good reason..
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.